Cargando…
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
Liquid biopsy is a common term referring to circulating tumor cells and other biomarkers, such as circulating tumor DNA (ctDNA) or extracellular vesicles. Liquid biopsy presents a range of clinical advantages, such as the low invasiveness of the blood sample collection and continuous control of the...
Autores principales: | Kamińska, Paula, Buszka, Karolina, Zabel, Maciej, Nowicki, Michał, Alix-Panabières, Catherine, Budna-Tukan, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468624/ https://www.ncbi.nlm.nih.gov/pubmed/34575876 http://dx.doi.org/10.3390/ijms22189714 |
Ejemplares similares
-
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
por: Buszka, Karolina, et al.
Publicado: (2022) -
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients
por: Kamińska, Paula, et al.
Publicado: (2023) -
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021) -
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023) -
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019)